全文获取类型
收费全文 | 348篇 |
免费 | 31篇 |
专业分类
儿科学 | 5篇 |
妇产科学 | 6篇 |
基础医学 | 65篇 |
口腔科学 | 5篇 |
临床医学 | 38篇 |
内科学 | 83篇 |
皮肤病学 | 2篇 |
神经病学 | 11篇 |
特种医学 | 96篇 |
外科学 | 42篇 |
综合类 | 5篇 |
预防医学 | 3篇 |
眼科学 | 3篇 |
药学 | 9篇 |
肿瘤学 | 6篇 |
出版年
2024年 | 1篇 |
2023年 | 1篇 |
2022年 | 1篇 |
2021年 | 3篇 |
2019年 | 3篇 |
2018年 | 4篇 |
2017年 | 1篇 |
2016年 | 3篇 |
2015年 | 6篇 |
2014年 | 7篇 |
2013年 | 13篇 |
2012年 | 11篇 |
2011年 | 9篇 |
2010年 | 13篇 |
2009年 | 7篇 |
2008年 | 15篇 |
2007年 | 16篇 |
2006年 | 18篇 |
2005年 | 9篇 |
2004年 | 17篇 |
2003年 | 18篇 |
2002年 | 10篇 |
2001年 | 12篇 |
2000年 | 3篇 |
1999年 | 8篇 |
1998年 | 9篇 |
1997年 | 11篇 |
1996年 | 13篇 |
1995年 | 10篇 |
1994年 | 11篇 |
1993年 | 7篇 |
1992年 | 6篇 |
1991年 | 5篇 |
1990年 | 4篇 |
1989年 | 9篇 |
1988年 | 11篇 |
1987年 | 11篇 |
1986年 | 11篇 |
1985年 | 10篇 |
1984年 | 3篇 |
1983年 | 5篇 |
1982年 | 7篇 |
1981年 | 4篇 |
1980年 | 12篇 |
1979年 | 1篇 |
1978年 | 3篇 |
1977年 | 1篇 |
1976年 | 3篇 |
1975年 | 2篇 |
1973年 | 1篇 |
排序方式: 共有379条查询结果,搜索用时 15 毫秒
21.
Differential CT diagnosis of extruded nucleus pulposus 总被引:1,自引:0,他引:1
22.
23.
Although it is clear that the specific antigenic reactivity of antiphospholipid (aPL) antibodies is critical to their effect, the pathogenic mechanisms that result in injury in vivo are incompletely understood. We hyphothesized that aPL antibodies targeted to the placenta activate complement locally, generating split products that mediate placental injury and lead to foetal loss and growth retardation. To test this hypothesis, we used a murine model of APS in which pregnant mice are injected with human IgG containing aPL antibodies. Mice treated with inhibitors of complement activation and mice deficient in complement components were protected from aPL antibody-induced foetal damage. Although the cause of tissue injury in this disease is probably multifactoral, we have shown that complement activation is an absolute requirement for foetal loss and growth restriction and, therefore, thatthis pathway acts upstream of other important effector mechanisms. Identification of complement activation as a mechanism that is necessary for aPL-induced tissue damage and definition ofthe complement components necessary to trigger such injury is likely to lead to a better understanding of the pathogenesis of vascular and tissue injury in SLE and to new and improved treatments. 相似文献
24.
Expression of a soluble complement inhibitor protects transgenic mice from antibody-induced acute renal failure 总被引:2,自引:0,他引:2
Schiller B Cunningham PN Alexander JJ Bao L Holers VM Quigg RJ 《Journal of the American Society of Nephrology : JASN》2001,12(1):71-79
Crry is a potent complement regulator in rodents that inhibits C3 convertases. In rats, intrarenal arterial injection of anti-glomerular endothelial cell (GEN) antibodies leads to complement-dependent microvascular injury and acute renal failure. In this study, a mouse variant of this model and the effects of complement inhibition were examined. Transgenic mice that overexpressed soluble Crry systemically and in their kidneys were studied. Anti-GEN IgG was injected intravenously into eight Crry transgenic mice and seven transgene-negative littermates (which were used as control animals). Thirty h after injection, blood urea nitrogen (BUN) levels were 30.3 +/- 4.4 and 114.8 +/- 23.5 mg/dl for transgene-positive and -negative animals, respectively (P = 0.012). Four of five transgene-negative animals with BUN levels of > 100 mg/dl were anuric; the remaining animal exhibited minimal albuminuria and no detectable urinary C3. In animals with renal failure, glomerular capillary collapse and tubular necrosis were observed. There was significant tubular staining for C3 in transgene-negative animals, with cellular and basal distributions, both of which were statistically greater than those in transgene-positive animals. Tubular cell C3 staining was strongly correlated with BUN values (r = 0.83, P < 0.001), as was C9 staining (r = 0.56, P = 0.037), suggesting that complement activation to the C5b-9 membrane attack complex had a casual role in renal failure. Thus, systemic injection of anti-GEN antibodies into mice leads to acute renal failure, with glomerular and tubular injury. Animals that overexpress soluble Crry in renal tubules and elsewhere are protected from the acute renal failure that occurs in this model, which ultimately seems to develop because of complement activation focused on tubules. 相似文献
25.
26.
Pineal germinoma: MR imaging 总被引:6,自引:0,他引:6
Magnetic resonance (MR) imaging characteristics of pineal germinomas are described in seven patients imaged with MR and computed tomography (CT). In patients with symptoms of an enlarging process in the quadrigeminal plate cistern, MR imaging was as sensitive as CT scanning in detecting the mass. MR imaging did not detect a normal-sized, calcified neoplastic gland. Germinoma, germinoma with embryonal cell carcinoma elements, and pineoblastoma demonstrated different MR signal characteristics. Although direct coronal and sagittal MR images were useful in defining the relationship of the tumor to the posterior third ventricle, Sylvian aqueduct, and vein of Galen, the ease, rapidity, and sensitivity of CT scanning suggest that CT should remain the modality of choice for initial evaluation and screening of the pineal region, especially in the younger pediatric population, in whom detection of calcification may provide the only clue of an abnormality. 相似文献
27.
Objective. This study documents and traces the evolution of triple rhythm (Waltz) linking the great veins, corresponding systemic or
pulmonary venous sinuses and pectinated right or left atrium in frog, turtle, snake and human hearts. Alternating rhythm (duet)
between systemic and pulmonary veins has also been documented in these hearts.
Material Studied. The hearts of six dead hammer-head sharks were examined with the naked eye. Air-breathing, fresh-water fish (three Channa
striata and three Indian catfish) were anaesthetised with ketamine and their pharynx insufflated with oxygen. Six frogs, three
turtles, and two snakes were anaesthetised, intubated and ventilated. Contractions of the exposed hearts of these animals
were correlated with their electrocardiograms using superimposed videos. The human heart was observed carefully during surgery
through median sternotomy or anterolateral thoracotomy by visual inspection especially during instillation of or recovery
from cardioplegia. Digital videos were taken and studied in slow motion replay later.
Observations. In the air-breathing fish, Channa striata and Indian catfish and presumably the shark, the cardinal veins and thin walled
sinus venosus do not contract. In the frog, turtle, and snake there is sequential contraction of the systemic veins, systemic
venous sinus and pectinated right atrium. Likewise, there is waltz on the arterial side. There is a duet between systemic
and pulmonary veins, contractions of the former preceding the latter in the frog, turtle and snake. The observations are similar
in the human heart except that the inferior vena cava does not contract.
Conclusions. There is sequential contraction of the superior vena cava, the systemic venous sinus and the pectinated part of the right
atrium in the human heart. Likewise, there is a waltz linking the terminal pulmonary veins, pulmonary venous sinus and pectinated
part of the left atrium in the human heart. This waltz or triple rhythm, as well as a duet between the systemic and pulmonary
veins are seen in frog, turtle and snake. The duet is also observable in the human heart, during recovery from cardioplegia.
It is likely that the waltz and duet are conducted by a neurogenic mechanism.
Clinical Implications. The understanding, preservation and restoration of the mechanism sustaining supraventricular waltz and duet is relevant
to surgical and interventional procedures for control of atrial arrhythmia, Fontan circulation, technique for cardiac transplantation
and planning atriotomies. 相似文献
28.
Daniels DL; Czervionke LF; Millen SJ; Haberkamp TJ; Meyer GA; Hendrix LE; Mark LP; Williams AL; Haughton VM 《Radiology》1989,171(3):807-809
The authors evaluated magnetic resonance (MR) images obtained with intravenously administered gadolinium in ten patients who had facial paralysis and no facial nerve tumor. In patients with either Bell palsy (four patients) or facial paralysis after temporal bone surgery (six patients), intratemporal facial nerve enhancement was seen. Facial nerve enhancement on MR images proved to be a nonspecific finding. 相似文献
29.
Molecular cloning of a murine fibronectin receptor and its expression during inflammation. Expression of VLA-5 is increased in activated peritoneal macrophages in a manner discordant from major histocompatibility complex class II 总被引:6,自引:0,他引:6
下载免费PDF全文
![点击此处可从《The Journal of experimental medicine》网站下载免费的PDF全文](/ch/ext_images/free.gif)
V M Holers T G Ruff D L Parks J A McDonald L L Ballard E J Brown 《The Journal of experimental medicine》1989,169(5):1589-1605
30.
John A. Kessler Aziz Shaibani Christine N. Sang Mark Christiansen David Kudrow Aaron Vinik Nari Shin the VM study group 《CTS Clinical and Translational Science》2021,14(3):1176
AbstractVM202 is a plasmid DNA encoding two isoforms of hepatocyte growth factor (HGF). A previous phase II study in subjects with painful diabetic peripheral neuropathy (DPN) showed significant reductions in pain. A phase III study was conducted to evaluate the safety and efficacy of VM202 in DPN. The trial was conducted in two parts, one for 9 months (DPN 3‐1) with 500 subjects (VM202: 336 subjects; and placebo: 164) and a preplanned subset of 101 subjects (VM202: 65 subjects; and placebo: 36) with a noninterventional extension to 12 months (DPN 3‐1b). VM202 or placebo was administered to calf muscles on days 0 and 14, and on days 90 and 104. The primary end point in DPN 3‐1 was change from baseline in the mean 24‐h Numerical Rating Scale (NRS) pain score. In DPN 3‐1b, the primary end point was safety, whereas the secondary efficacy end point was change in the mean pain score. VM202 was well‐tolerated in both studies without significant adverse events. VM202 failed to meet its efficacy end points in DPN 3‐1. In DPN 3‐1b, however, VM202 showed significant and clinically meaningful pain reduction versus placebo. Pain reduction in DPN 3‐1b was even greater in subjects not receiving gabapentin or pregabalin, confirming an observation noted in the phase II study. In DPN 3‐1b, symptomatic relief was maintained for 8 months after the last injection suggesting that VM202 treatment might change disease progression. Despite the perplexing discrepancy between the two studies, the safety and long‐lasting pain‐relieving effects of VM202 observed in DPN 3‐1b warrant another rigorous phase III study. Study Highlights
- WHAT IS THE CURRENT KNOWLEDGE ON THE TOPIC?
- WHAT QUESTION DID THIS STUDY ADDRESS?
- WHAT DOES THIS STUDY ADD TO OUR KNOWLEDGE?
- HOW MIGHT THIS CHANGE CLINICAL PHARMACOLOGY OR TRANSLATIONAL SCIENCE?